Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Fangdi Sun, MD

Photo of Fangdi Sun, MD
Title(s)Volunteer Clinical Instructor, Medicine
SchoolSchool of Medicine
AddressLocation Required, #001
Phone415-885-7788
ORCID ORCID Icon0000-0002-5917-6209 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California, San Francisco, CAChief Residency2022Internal Medicine
    University of California, San Francisco, CAResidency2021Internal Medicine
    Harvard Medical School, Boston, MAMD2018
    Massachusetts Institute of Technology, Cambridge, MABS2014Biological Engineering

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cisplatin, immunotherapy, and chemoradiation in nasopharyngeal carcinoma: How far should one trial move the needle? Med. 2025 Nov 14; 6(11):100917. Sun F, Colevas AD. PMID: 41240897.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study. Ann Oncol. 2026 Jan; 37(1):104-116. Zheng MM, Xia Y, Pan K, Sun F, Tan AC, Dong XR, Tu HY, Tang LB, Li YS, Yin K, Borgeaud M, Singhal S, Zhu E, Zhang J, Nilsson M, Wu J, Gibbons DL, Wakelee H, Neal JW, Lee J, Vaporciyan AA, Ringsurongkawong W, Tran HT, Zhang RZ, Zhang T, Zhou Q, Zhong WZ, Li W, Zhang YC, Riess JW, Addeo A, Heymach JV, Myall N, Tan D, Wu YL, Le X. PMID: 41125209.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer. Lung Cancer. 2025 Oct; 208:108747. Sun F, Banwait MK, Singhal S, Herrmann A, Piotrowska Z, Yun K, Bazhenova L, Ullah AT, Guo EW, Wakelee HA, Neal JW, Das MS, Ramchandran KJ, Roy M, Diehn M, Myall NJ. PMID: 40957338; PMCID: PMC12937006.
      View in: PubMed   Mentions:    Fields:    
    4. Brief Report: Safety of Pulse-Dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-Mutated Nonsmall Cell Lung Cancer. Clin Lung Cancer. 2025 Nov; 26(7):603-609.e2. Sun F, Nagpal S, Singhal S, Neal JW, Wakelee HA, Myall NJ, Bolan P, Riess JW, Gandara DR, Das MS. PMID: 40885626; PMCID: PMC12937019.
      View in: PubMed   Mentions:    Fields:    
    5. Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer. J Immunother Cancer. 2025 Jul 15; 13(7). Miller NJ, Baik C, Neal JW, Sun F, Santana-Davila R, Lee S, Eaton KD, Martins RG, Rodriguez C, Wakelee H, Padda SK, Sotillo E, Konnick EQ, Camai A, Pisarenko T, Nair VS, Mackall C, Houghton AM, Chiou SH, Tseng D. PMID: 40664448; PMCID: PMC12265838.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Characteristics of Short-Term Survivors With ALK or ROS1-Altered Metastatic NSCLC. JTO Clin Res Rep. 2025 Nov; 6(11):100876. Liu KL, Watts A, Grady CB, Liu G, Patel D, Balaratnam K, Liu SV, Montenegro GB, Nie Y, Nieva J, Herrmann A, Marrone K, Lam V, Sun F, Dowell J, Schwartzman W, Velcheti V, Fankuchen O, Ullah T, Villaruz L, Nguyen M, Weiss J, Patel S, Miller K, Iams W, Chandrasekhara K, Tompkins W, Patil T, Aisner D, Camidge DR, Hwang WT, Sun L, Marmarelis ME. PMID: 41235297; PMCID: PMC12605057.
      View in: PubMed   Mentions: 1  
    7. FLAURA2: evidence for escalated first-line therapy in EGFR-mutated non-small cell lung cancer with central nervous system metastases. Transl Cancer Res. 2025 Jun 30; 14(6):3295-3301. Sun F, Neal JW, Myall NJ. PMID: 40687261; PMCID: PMC12268507.
      View in: PubMed   Mentions: 2  
    8. Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis. Lung Cancer. 2025 May; 203:108551. Barsouk A, Elghawy O, Watts A, Reed-Guy L, Tompkins W, Chandrasekhara K, Grady CB, Iams W, Sun F, Liu G, Patel D, Nieva JJ, Marrone KA, Velcheti V, Liu SV, Patil T, Weiss J, Schwartzman W, Villaruz LC, Hermann A, Aisner DL, Hwang WT, Camidge DR, Sun L, Singh AP, Cohen RB, Aggarwal C, Langer CJ, Marmarelis ME. PMID: 40262226.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Checkpoint Inhibitor Immunotherapy to Treat Temozolomide-Associated Hypermutation in Advanced Atypical Carcinoid Tumor of the Lung. JCO Precis Oncol. 2022 06; 6:e2200009. Sun F, Grenert JP, Tan L, Van Ziffle J, Joseph NM, Mulvey CK, Bergsland E. PMID: 35737914; PMCID: PMC9249272.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    10. In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?" J Thorac Oncol. 2022 02; 17(2):e12-e14. Thomas NJ, Myall NJ, Sun F, Patil T, Mushtaq R, Yu C, Sinha S, Pollom EL, Nagpal S, Camidge DR, Rusthoven CG, Braunstein SE, Wakelee HA, McCoach CE. PMID: 35074229.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Capturing what matters: A retrospective observational study of advance care planning documentation at an academic medical center during the COVID-19 pandemic. Palliat Med. 2022 02; 36(2):342-347. Sun F, Lipinsky DeGette R, Cummings EC, Deng LX, Hauser KA, Kopp Z, Penner JC, Scott BS, Raffel KE, Kantor MA. PMID: 34920691.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    12. Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With Radiation. J Thorac Oncol. 2022 01; 17(1):116-129. Thomas NJ, Myall NJ, Sun F, Patil T, Mushtaq R, Yu C, Sinha S, Pollom EL, Nagpal S, Camidge DR, Rusthoven CG, Braunstein SE, Wakelee HA, McCoach CE. PMID: 34455066.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    13. Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer. Curr Treat Options Oncol. 2021 06 24; 22(8):72. Sun F, McCoach CE. PMID: 34165651.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    14. Incidence of peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer. Breast Cancer Res Treat. 2019 Jun; 175(3):649-658. Daniell KM, Bardia A, Sun F, Roberts SA, Brunelle CL, Gillespie TC, Sayegh HE, Naoum GE, Juric D, Isakoff SJ, Fitzgerald DM, Taghian AG. PMID: 30919166.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema. Breast Cancer Res Treat. 2018 Nov; 172(1):83-91. Sun F, Hall A, Tighe MP, Brunelle CL, Sayegh HE, Gillespie TC, Daniell KM, Taghian AG. PMID: 30062571; PMCID: PMC6191334.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    16. Letter to the editor of "Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: A best practice guideline" from N. Gebruers and colleagues. Eur J Obstet Gynecol Reprod Biol. 2018 06; 225:255-256. Sun F, Brunelle CL, Daniell KM, Gillespie TC, Sayegh HE, Taghian AG. PMID: 29573838.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Amino Acid Uptake Measured by [18F]AFETP Increases in Response to Arginine Starvation in ASS1-Deficient Sarcomas. Theranostics. 2018; 8(8):2107-2116. Prudner BC, Sun F, Kremer JC, Xu J, Huang C, Sai KKS, Morgan Z, Leeds H, McConathy J, Van Tine BA. PMID: 29721066; PMCID: PMC5928874.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    18. Cytosolic delivery of siRNA by ultra-high affinity dsRNA binding proteins. Nucleic Acids Res. 2017 Jul 27; 45(13):7602-7614. Yang NJ, Kauke MJ, Sun F, Yang LF, Maass KF, Traxlmayr MW, Yu Y, Xu Y, Langer RS, Anderson DG, Wittrup KD. PMID: 28641400; PMCID: PMC5570165.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    19. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema. Breast Cancer Res Treat. 2016 06; 157(2):229-240. Sun F, Skolny MN, Swaroop MN, Rawal B, Catalano PJ, Brunelle CL, Miller CL, Taghian AG. PMID: 27154787.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    Fangdi's Networks
    Concepts (86)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-21-g9d46e6c4 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.